| Publication Type | journal article |
| School or College | School of Medicine |
| Department | Ophthalmology |
| Creator | Zhang, Kang |
| Other Author | Kniazeva, M; Chiang, M F; Morgan, B; Anduze, A L; Zack, D J; Han, M |
| Title | New locus for autosomal dominant stargardt-like disease maps to chromosome 4 |
| Date | 1999 |
| Description | Stargardt disease (STGD) is the most common hereditary macular dystrophy and is characterized by decreased central vision, atrophy of the macula and underlying retinal-pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD is most commonly inherited as an autosomal recessive trait, but many families have been described in which features of the disease are transmitted in an autosomal dominant manner. A recessive locus has been identified on chromosome 1p (STGD1), and dominant loci have been mapped to both chromosome 13q (STGD2) and chromosome 6q (STGD3). In this study, we describe a kindred with an autosomal dominant Stargardt-like phenotype. A genomewide search demonstrated linkage to a locus on chromosome 4p, with a maximum LOD score of 5.12 at a recombination fraction of.00, for marker D4S403. Analysis of extended haplotypes localized the disease gene to an approximately 12-cM interval between loci D4S1582 and D4S2397. Therefore, this kindred establishes a new dominant Stargardt-like locus, STGD4. |
| Type | Text |
| Publisher | University of Chicago Press |
| Volume | 64 |
| Issue | 5 |
| First Page | 1394 |
| Last Page | 1399 |
| Subject | Haplotypes; Genetic Markers |
| Subject MESH | Chromosome Mapping; Chromosomes, Human, Pair 4; Macular Degeneration; Lod Score |
| Language | eng |
| Bibliographic Citation | Kniazeva M, Chiang MF, Morgan B, Anduze AL, Zack DJ, Han M, Zhang K. (1999). A new locus for autosomal dominant stargardt-like disease maps to chromosome 4. Am J Hum Genet, 64(5), 1394-9 |
| Rights Management | © University of Chicago Press |
| Format Medium | application/pdf |
| Identifier | ir-main,1795 |
| ARK | ark:/87278/s6xs6cjt |
| Setname | ir_uspace |
| ID | 702887 |
| OCR Text | Show Am. J. Hum. Genet. 64:1394-1399, 1999 1394 A New Locus for Autosomal Dominant Stargardt-Like Disease Maps to Chromosome 4 Marina Kniazeva,1 Michael F. Chiang,2 Basil Morgan,2 Alfred L. Anduze,4 Donald J. Zack,2,3 Min Han,1 and Kang Zhang2 1Department of Molecular, Cellular, and Developmental Biology, Howard Hughes Medical Institute, University of Colorado, Boulder; 2Department of Ophthalmology, Wilmer Eye Institute, and 3Departments of Molecular Biology and Genetics, and Neuroscience, Johns Hopkins University School of Medicine, Baltimore; and 4Island Medical Center, Saint Croix, U.S. Virgin Islands Summary Stargardt disease (STGD) is the most common he- reditary macular dystrophy and is characterized by de- creased central vision, atrophy of the macula and un- derlying retinal-pigment epithelium, and frequent pres- ence of prominent flecks in the posterior pole of the retina. STGD is most commonly inherited as an auto- somal recessive trait, but many families have been de- scribed in which features of the disease are transmitted in an autosomal dominant manner. A recessive locus has been identified on chromosome 1p (STGD1), and dom- inant loci have been mapped to both chromosome 13q (STGD2) and chromosome 6q (STGD3). In this study, we describe a kindred with an autosomal dominant Star- gardt-like phenotype. A genomewide search demon- strated linkage to a locus on chromosome 4p, with a maximum LOD score of 5.12 at a recombination frac- tion of .00, for marker D4S403. Analysis of extended haplotypes localized the disease gene to an ➺ 12-cM in- terval between loci D4S1582 and D4S2397. Therefore, this kindred establishes a new dominant Stargardt-like locus, STGD4. Introduction Age-related macular degeneration (AMD) represents a heterogeneous group of retinal disorders and is the most common cause of irreversible blindness among elderly individuals in the United States (Bressler et al. 1988). Stargardt disease (STGD) shows some similarities to Received November 18, 1998; accepted for publication February 26, 1999; electronically published April 8, 1999. Address for correspondence and reprints: Dr. Marina Kniazeva, Department of Molecular, Cellular, and Developmental Biology, Cam- pus Box 347, University of Colorado, Boulder, CO 80309. E-mail: marinak@colorado.edu q 1999 by The American Society of Human Genetics. All rights reserved. 0002-9297/99/6405-0019$02.00 AMD. It is the most common hereditary macular dys- trophy, with a prevalence of ➺ 1/10,000. Clinically, STGD is characterized by decreased central vision during the first several decades of life, bilateral "bull's-eye" at- rophy or a "beaten-bronze" appearance of the macula and underlying retinal-pigment epithelium, and frequent presence of prominent yellow "flavimaculatus flecks" in the posterior pole of the retina (Stargardt 1909; Hadden and Gass 1976; Noble and Carr 1979). Fluorescein an- giography reveals a virtually pathognomonic "dark cho- roid" pattern (Fish et al. 1981). Electroretinography is normal early in the course of the disease but often shows mild to moderate abnormalities in late stages (Fishman 1976). Classically, STGD is inherited in an autosomal reces- sive manner. A recessive locus has been mapped to chro- mosome 1p (STGD1 [MIM 248200]), and the corre- sponding gene on chromosome 1p has been cloned (Kaplan et al. 1993; Allikmets et al. 1997b). This gene encodes a retina-specific transmembrane protein, ABCR, which belongs to the ATP-binding cassette family of membrane transporters. It is of particular interest that mutations in the ABCR gene have been reported in a subset of patients with AMD (Allikmets et al. 1997a), although it should be noted that the interpretation of this finding is controversial (Dryja et al. 1998; Klaver et al. 1998; Stone et al. 1998). In addition to the more common recessive pattern, many families have been de- scribed in which features of STGD are transmitted in an autosomal dominant manner (Cibis et al. 1980; Lopez et al. 1990; Mansour 1992; Stone et al. 1994; Zhang et al. 1994). Dominant loci have been mapped to chro- mosome 13q (STGD2 [MIM 153900]) and to chro- mosome 6q (STGD3 [MIM 600110]) (Stone et al. 1994; Zhang et al. 1994). In this report, we describe a kindred affected with an autosomal dominant form of STGD mapping to a new disease locus, on chromosome 4. In accordance with the guidelines of the HUGO Nomenclature Committee, the gene causing this disorder has been designated "STGD4." Linkage was established with a two-point maximum LOD score (Zmax) of 5.12 at , between ✈ ✺ .00 Kniazeva et al.: Stargardt-Like Locus on Chromosome 4 1395 Figure 1 Fundus photograph and fluorescein angiogram from right eye of patient III-13, a 33-year-old woman with decreased vision since age 15 years. Visual acuity was 20/400 in the right eye and 20/ 50 in the left eye. A, Fundus photograph showing bull's-eye macular atrophy. B, Fluorescein angiogram revealing dark-choroid pattern, as well as central retinal epithelial atrophy surrounded by numerous hy- perfluorescent spots consistent with flavimaculatus flecks. the disease and marker locus D4S403, and a 10-cM crit- ical region between marker loci D4S1582 and D4S2397 was identified by analysis of extended haplotypes. Subjects and Methods Subjects Informed consent was obtained from all participants, in accordance with the guidelines established by the Johns Hopkins University School of Medicine, Balti- more. Twenty-six members of a three-generation, non- consanguineous Caribbean family were identified for study. A complete ophthalmic history was obtained, and an examination was performed on each subject. Indi- viduals were considered to be affected on the basis of the presence of decreased visual acuity and bull's-eye or similar macular atrophy. Fluorescein angiography was done in four affected subjects, and two affected subjects underwent electroretinographic testing. Genomic DNA Isolation and Genotype Analysis Blood was collected from family members by veni- puncture, and genomic DNA was isolated with the QIAamp ② blood kit (Qiagen), according to the manu- facturer's instructions. All DNA samples were analyzed with polymorphic short tandem repeat (STR) markers spanning 22 autosomes, with a step of ➺ 24.2 cM (Re- search Genetics). PCR was performed according to the manufacturer's protocol (Research Genetics). In most cases, multiplex PCR was used. After amplification, PCR fragments were separated on a denaturing 6% poly- acrylamide gel, and bands were visualized by exposure of the dry gel to x-ray film (Kodak). Linkage Analysis Two-point and multipoint linkage analysis was con- ducted with the LINKAGE (version 5.1) package (La- throp et al. 1985). Linkage analysis was done under conditions of no sex differences in recombination, com- plete disease penetrance, and disease-gene frequency of 1/10,000. Allele frequencies for the markers used were determined by the genotyping of 40 additional chro- mosomes. The reference genetic map used for linkage analysis was obtained from the Human Gene Map (Dib et al. 1996). Haplotype Analysis Extended haplotypes of the individuals were con- structed according to the order of STR markers in the Ge´ne´thon genetic linkage map (Dib et al. 1996). Re- construction of haplotypes was done, whenever possible, for individuals whose DNA samples were not available. Results Clinical Examination Twelve of the 18 individuals at risk for inheriting the disease were found to be affected, on the basis of the presence of decreased visual acuity and macular atrophy (fig. 1A). Fluorescein angiography was done in four af- fected subjects, all of whom demonstrated the charac- teristic dark-choroid pattern of STGD. Three of the four fluorescein angiograms revealed typical STGD flavima- culatus flecks (fig. 1B). In addition, two affected subjects underwent electroretinographic testing. One of these in- dividuals had a normal rod-photoreceptor response and a mildly decreased cone-photoreceptor response, and the other had a very mildly reduced rod response and a mildly reduced cone response (authors' unpublished Figure 2 Autosomal dominant Stargardt-like-disease pedigree. Boxes indicate the disease haplotypes. Squares denote males; circles denote females; blackened symbols denote affected individuals; unblackened symbols denote unaffected individuals; a diagonal slash through a symbol denotes that the individual is deceased; dashes (-) denote that data were not available. 2 STR 4 4 Genetic Markers: 2 4 0483007 2 5 0481582 3 2 0452639 1 1 3 2 0452944 5 5 0451602 4 3 045403 0451601 0482397 2 3 4 6 II [D4 3 - 2 - 2 4 1 1 2 3 - 4 - 4 4 4 3 5 5 - 2 - 1 7 4 3 2 4 - 3 2 3 3 2 4 1 3 - 5 4 3 5 2 6 2 4 5 6 - 1 7 3 4 4 1 5 1 6 2 3 5 3 3 2 - 6 3 5 2 3 2 3 4 5 6 7 8 9 10 11 12 13 14 15 III 3 4 4 4 1 2 2 4 1 4 4 4 2 4 1 4 1 2 1 4 3 2 4 4 1 4 4 4 1 4 2 4 4 2 1 4 1 4 4 4 5 5 ~6 5 2 2 5 5 7 2 7 1 2 5 7 5 1 4 2 4 2 3 2 3 3 2 2 3 3 3 3 3 3 3 3 3 3 2 3 3 1 5 1 5 5 4 1 5 5 1 5 3 1 5 5 5 3 2 1 4 2 8 6 8 1 7 2 8 4 3 4 3 3 8 4 8 3 4 3 1 5 4 5 4 1 6 5 4 3 5 3 2 5 4 3 4 2 5 5 2 3 1 3 1 6 3 3 5 4 5 2 4 5 1 2 3 4 Kniazeva et al.: Stargardt-Like Locus on Chromosome 4 1397 Table 1 Two-Point LOD Scores between Dominant Stargardt-Like Disease and DNA Markers MARKER LOD SCORE AT ✈ ✺ .00 .01 .06 .11 .16 .21 .26 .31 .36 .41 D4S3007 ✷❵ -2.12 .09 .69 .94 1.03 1.01 .91 .75 .53 D4S1582 ✷❵ -.13 1.28 1.60 1.66 1.60 1.46 1.26 1.00 .69 D4S2639 4.21 4.15 3.81 3.45 3.08 2.68 2.26 1.81 1.35 .87 D4S2944 .55 .51 .50 .46 .43 .38 .32 .26 .19 .12 D4S1602 4.82 4.74 4.36 3.96 3.53 3.08 2.60 2.09 1.56 1.012 D4S403 5.12 5.04 4.63 4.20 3.76 3.28 2.77 2.23 1.67 1.08 D4S1601 4.82 4.74 4.36 3.96 3.53 3.08 2.60 2.09 1.56 1.01 D4S2397 ✷❵ .16 1.42 1.64 1.65 1.56 1.39 1.18 .93 .63 Figure 3 Graph of multipoint LOD score, with genetic distance (in morgans) plotted versus the LOD score. The location of D4S3007 marker is considered to be at map position 0. The dotted line is drawn at y , to show a support interval for the maximum-likeli- ✺ Z ✷ 3 max hood estimate. data). A pedigree was constructed, with affected mem- bers of both sexes in each generation (fig. 2). Taken together, these data are consistent with autosomal dom- inant transmission of a Stargardt-like disease. Genetic-Linkage Studies Polymorphic STR markers previously known to be linked to STGD, cone dystrophy (COD), and cone-rod dystrophy (CORD) were examined first. The analyzed loci included STGD2 on 13q34 (Zhang et al. 1994), STGD3 on 6q (Stone et al. 1994), COD3 (MIM 602093) on 6p21 (Payne et al. 1998), CORD2 (MIM 120970) on 19q13 (Evans et al. 1994; Freund et al. 1997; Swain et al. 1997), CORD5 (MIM 600977) on 17p (Small et al. 1996), and CORD6 (MIM 601777) on chromosome 17p12-p13 (Kelsell et al. 1997). No significant linkage was found to any of these loci. A genomewide scan with 147 STR markers was per- formed, and linkage was found after 59% of the genome was excluded as a location of the disease gene. Two- point linkage analysis revealed a locus on chromosome 4, with Z at , for marker D4S403 (ta- 5.12 ✁ .00 max ble 1). Linkage analysis was refined with 14 additional STR markers spanning a 32-cM region centered around marker D4S403. The LOD scores for loci D4S2639, D4S1602, and D4S1601 also satisfied the Morton (1955) criterion, reaching Z at . Mul- ✶ 4.0 ✁ .00 max tipoint linkage analysis (fig. 3) localized the disease in- terval to a region between markers D4S1582 and D4S2397, with 3-unit-LOD-score support interval ➺ 10-22 cM to the right of marker D4S3007. Haplotype Analysis Extended haplotypes were constructed on the basis of the following order of markers: D4S3007- D4S1582-D4S2639-D4S2944-D4S1602-D4S403- D4S1601-D4S2397 (fig. 2). These loci represent a re- gion 12-32 cM from the top of the chromosome. The presumptive disease-associated haplotype was deter- mined as a common extended haplotype for all af- fected individuals. Eight informative recombination events were identified in the family. On the basis of these results, the disease interval was localized be- tween markers D4S1582 and D4S2397 on chromo- some 4p. Within the region, no recombinations were detected at loci D4S2639, D4S2944, D4S1602, D4S403, and D4S1601. Discussion STGD was originally described as an autosomal re- cessive trait (Stargardt 1909). STGD1, a chromosome 1p gene responsible for autosomal recessive STGD, has recently been cloned (Allikmets et al. 1997b). Autosomal dominant inheritance of a Stargardt-like phenotype is less common but has been described in a number of families (Cibis et al. 1980; Lopez et al. 1990; Mansour 1992; Stone et al. 1994; Zhang et al. 1994). Previous studies have identified two loci for dominant Stargardt- like disease: STGD2 and STGD3 (Stone et al. 1994; 1398 Am. J. Hum. Genet. 64:1394-1399, 1999 Zhang et al. 1994). In the present study, we have per- formed genetic-linkage analysis of a kindred affected with autosomal dominant Stargardt-like disease. A ge- nomewide search identified a chromosome 4 region con- taining the disease gene, with several STR markers coseg- regating with the disease phenotype. A two-point Zmax of 5.12 at was obtained between the disease and ✈ ✺ .00 marker locus D4S403. Multipoint analysis and analysis of extended haplotypes disclosed recombination events that restricted the disease interval to an ➺ 12-cM region between markers D4S1582 and D4S2397. This defines a new locus, STGD4, for autosomal dominant Stargardt- like disease. A candidate-gene search of a gene map of the human genome (Deloukas et al. 1998) identified two genes in this region that are expressed in the retina. The first gene encodes dihydropyrimidinase-related protein-1 (DRP-1) and has been mapped by Ge´ne´thon by means of the radiation-hybrid panel. The biological function of DRP- 1 is unknown, but two homologous proteins, DRP-2 and DRP-3, are thought to play a role in neuronal growth and maturation (Hamajima et al. 1996). The second gene encodes heat-shock protein 90 (HSP90 [MIM 140572]). It has been mapped by the Whitehead Institute for Biomedical Research/MIT Center for Genome Re- search by means of a YAC panel and belongs to a family of stress-inducible proteins (Rebbe et al. 1989). Heat- shock proteins are associated with various cellular sig- naling proteins and are believed to maintain tissue in- tegrity against thermal, oxidative, and mechanical stresses. In particular, HSP90 has been shown to be ex- pressed in rodents during visual-system development (Kojima et al. 1996). The study of STGD and other hereditary macular dys- trophies may have important implications for the study of AMD, which is the most common cause of irreversible blindness among elderly individuals in the United States. Historically, the genetic study of AMD has been limited by the clinical heterogeneity, late onset, and multifac- torial etiology of the disease (Heiba et al. 1994; Seddon et al. 1996, 1997). STGD provides a useful model for the genetic and molecular study of macular degenera- tion, because of its numerous phenotypic and histo- pathological similarities to AMD, including progres- sively decreased vision, atrophy of the macula and retinal-pigment epithelium, dysfunction of retinal pho- toreceptors, and accumulation of debris within the ret- inal-pigment epithelium (Young 1987). In light of these similarities, it is reasonable to hypothesize that the ge- netic basis and pathogenesis of Stargardt-like macular dystrophy may be related to those of certain subsets of AMD. Consistent with this hypothesis is a recent report that certain ABCR sequence changes are found more commonly in persons with AMD(Allikmets et al. 1997a; van Driel et al. 1998), although these data remain con- troversial (Dryja et al. 1998; Klaver et al. 1998; Stone et al. 1998). Cloning of the STGD4 gene, as well as further genetic and molecular study of hereditary macular dystrophies, should provide important insights into the pathogenesis of AMD. Compilation and analysis of other genes in- volved in macular dystrophies and AMD may eventually produce a more rational classification system for the various forms of macular degeneration. Finally, the dis- covery of specific genetic alterations in macular degen- eration could create opportunities to improve clinical diagnosis and to offer more-effective, targeted therapies for patients. Acknowledgments This work was supported by the Howard Hughes Medical Institute and funds from the National Institutes of Health Core Grant; Fight for Sight the Research Division of Prevent Blind- ness America; Research to Prevent Blindness; the Foundation Fighting Blindness; and the Mrs. Harry S. Duffy Research Fund. The authors wish to thank J. Zawistowski and M. Ker- rigan for their technical assistance, S. Coldfield and J. Sunness for performing the electroretinograms, and J. Seddon for his photographic expertise. The generosity and cooperation of the family members who participated in the study is particularly appreciated. Electronic-Database Information Accession numbers and URLs for data in this article are as follows: Ge´ne´thon, http://www.genethon.fr Human Gene Map, http://www.ncbi.nlm.nih.gov/SCIENCE96 Online Mendelian Inheritance in Man (OMIM), http:// www.ncbi.nlm.nih.gov/Omim (for AMD, COD3 [MIM 602093], CORD2 [MIM 120970], CORD5 [MIM 600977], CORD6 [MIM 601777], HSP90 [MIM 140572], STGD1 [MIM 248200], STGD2 [MIM 153900], and STGD3 [MIM 600110]) Whitehead Institute, http://www.genome.wi.mit.edu (for ge- netic markers) References Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, et al (1997a) Mutation of the Star- gardt disease gene (ABCR) in age-related macular degen- eration. Science 277:1805-1807 Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, et al (1997b) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mu- tated in recessive Stargardt macular dystrophy. Nat Genet 15:236-246 Bressler NM, Bressler SB, Fine SL (1988) Age-related macular degeneration. Surv Ophthalmol 32:375-413 Cibis GW, Morey M, Harris DJ (1980) Dominantly inherited Kniazeva et al.: Stargardt-Like Locus on Chromosome 4 1399 macular dystrophy with flecks (Stargardt). Arch Ophthalmol 98:1785-1789 Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tome P, Hui L, et al (1998) A physical map of 30,000 human genes. Science 282:744-746 Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, et al (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154 Dryja TP, Briggs CE, Berson EL Rosenfeld PJ, Abitbol M (1998) ABCR gene and age-related macular degeneration. Science 279:1107 (http://www.sciencemag.org/cgi/content/ full/279/5354/1107a) Evans K, Fryer A, Inglehearn C, Duvall-Young J, Whittaker JL, Gregory CY, Butler R, et al (1994) Genetic linkage of cone-rod retinal dystrophy to chromosome 19q and evidence for segregation distortion. Nat Genet 6:210-213 Fish G, Grey R, Sehmi KS, Bird AC (1981) The dark choroid in posterior retinal dystrophies. Br J Ophthalmol 65: 359-363 Fishman GA (1976) Fundus flavimaculatus: a clinical classi- fication. Arch Ophthalmol 94:2061-2067 Freund CL, Gregory-Evans CY, Furukawa T, Papaioannou M, Looser J, Ploder L, Bellingham J, et al (1997) Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene (CRX) essential for maintenance of the pho- toreceptor. Cell 91:543-553 Hadden OB, Gass JDM (1976) Fundus flavimaculatus and Stargardt's disease. Am J Ophthalmol 82:527-539 Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M, Nonaka M (1996) A novel gene family defined by human dihydropyrimidinase and three related proteins with differ- ential tissue distribution. Gene 180:157-163 Heiba IM, Elston RC, Klein BEK, Klein R (1994) Sibling cor- relations and segregation analysis of age-related maculo- pathy: the Beaver Dam Study. Genet Epidemiol 11:51-67 Kaplan J, Gerber S, Larget-Piet D, Rozet JM, Dollfus H, Dufier JL, Odent S, et al (1993) A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromo- some 1. Nat Genet 5:308-311 Kelsell RE, Evans K, Gregory CY, Moore AT, Bird AC, Hunt DM (1997) Localisation of a gene for dominant cone-rod dystrophy (CORD6) to chromosome 17p. Hum Mol Genet 6:597-600 Klaver CCW, Assink JJM, Bergen AAB, van Duijin CM (1998) ABCR and age-related macular degeneration. Science 279:1107 (http://www.sciencemag.org/cgi/content/full/279/ 5354/1107a) Kojima M, Hoshimaru M, Aoki T, Takahashi JB, Ohtsuka T, Asahi M, Matsuura N, et al (1996) Expression of heat shock proteins in the developing rat retina. Neurosci Lett 205: 215-217 Lathrop GM, Lalouel JM, Julier C, Ott J (1985) Multilocus linkage analysis in humans: detection of linkage and esti- mation of recombination. Am J Hum Genet 37:482-498 Lopez PF, Maumenee IH, Cruz Z, Green WR (1990) Auto- somal-dominant fundus flavimaculatus: clinicopathologic correlation. Ophthalmology 97:798-809 Mansour AM (1992) Long-term follow-up of dominant mac- ular dystrophy with flecks (Stargardt). Ophthalmologica 205:138-143 Morton NE (1955) Sequential tests for the detection of linkage. Am J Hum Genet 7:277-318 Noble KG, Carr RE (1979) Stargardt's disease and fundus flavimaculatus. Arch Ophthalmol 97:1281-1285 Payne AM, Downes SM, Bessant DA, Taylor R, Holder GE, Warren MJ, Bird AC, et al (1998) A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chro- mosome 6p21.1. Hum Mol Genet 7:273-277 Rebbe NF, Hickman WS, Ley TJ, Stafford DW, Hickman S (1989) Nucleotide sequence and regulation of a human 90-kDa heat shock protein gene. J Biol Chem 264: 15006-15011 Seddon JM, Ajani UA, Mitchell BD (1997) Familial aggre- gation of age-related maculopathy. Am J Ophthalmol 123: 199-206 Seddon JM, Willett WC, Speizer FE, Hankinson SE (1996) A prospective study of cigarette smoking and age-related mac- ular degeneration in women. JAMA 276:1141-1146 Small KW, Syrquin M, Mullen L, Gehrs K (1996) Mapping of autosomal dominant cone degeneration to chromosome 17p. Am J Ophthalmol 121:13-18 Stargardt K (1909) U¨ber familia¨ re progressive Degeneration in der Makulagegend des Auges. Albrecht Graefes Arch Klin Exp Ophthalmol 71:534-549 Stone EM, Nichols BE, Kimura AE, Weingeist TA, Drack A, Sheffield VC (1994) Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic link- age to chromosome 6q. Arch Ophthalmol 112:765-772 Stone EM, Webster AR, Vandenburgh K, Streb LM, Hockey RR, Lotery AJ, Sheffield VC (1998) Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 20:328-329 Swain PK, Chen S,Wang QL, Affatigato LM, Coats CL, Brady KD, Fishman GA, et al (1997) Mutations in the cone-rod homeobox gene are associated with the cone-rod dystrophy photoreceptor degeneration. Neuron 19:1329-1336 van Driel MA, Maugeri A, Klevering BJ, Hoyng CB, Cremers FPM (1998) ABCR unites what ophthalmologists divide(s). Ophthalmic Genet 19:117-122 Young RW (1987) Pathophysiology of age-related macular de- generation. Surv Ophthalmol 31:291-306 Zhang K, Bither PP, Park R, Donoso LA, Siedman JG, Siedman CE (1994) A dominant Stargardt's macular dystrophy maps to chromosome 13q34. Arch Ophthalmol 112:759-764 |
| Reference URL | https://collections.lib.utah.edu/ark:/87278/s6xs6cjt |



